CeriBell (CBLL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on CeriBell (CBLL) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.05 of bullish evidence against -0.38 bearish.

CeriBell last closed at $24.86, +4.94% on the session.

Against the IVW growth benchmark the position is +4.02% over the forecast window.

The read is built from 12 underlying insights — 3 bullish and 9 bearish.

Agreement across those insights is 75%.

16 graded predictions for CBLL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks CeriBell in the 19th percentile on return on equity, where 100 is best.

CeriBell is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $909.17M.

StockMap tracks CeriBell as the 63rd largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite CeriBell ranks 90th of 133 in the group, against a group median of -0.21.